Search Within

William Douglas Tap

Formats
  1. Journal Article (194)
  2. Meeting Abstract (159)
  3. Review (12)
  4. Book Section (4)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (2)
  8. Research Letter (1)
Groups
  1. Department of Medicine (379)
  2. Sarcoma Service (379)
  3. Solid Tumor Oncology Division (379)
  4. GSK Faculty (159)
  5. Tow Center for Developmental Oncology (TCDO) (149)
  6. Department of Pathology and Laboratory Medicine (133)

More Groups

People
  1. Sandra D'Angelo (106)
  2. Cristina Antonescu (97)
  3. Mark Dickson (92)
  4. Samuel Singer (80)
  5. Mrinal Gounder (79)
  6. Mary Keohan (77)

More People

Years
  1. 2025 (21)
  2. 2024 (50)
  3. 2023 (34)
  4. 2022 (43)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Annals of Oncology (30)
  3. Clinical Cancer Research (27)
  4. Cancer Research (14)
  5. Modern Pathology (11)
  6. Lancet Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (109)
  2. American Association for Cancer Research (48)
  3. Oxford University Press (39)
  4. Elsevier Science, Inc. (22)
  5. Elsevier Inc. (21)
  6. Nature Publishing Group (19)

More Publishers

Results (379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion—A pathologic and molecular pitfall
    Journal Article

    Kao, Y. C.; Sung, Y. S.; Zhang, L.; Kenan, S.; Singer, S.; Tap, W. D.; Swanson, D.; Dickson, B. C.; Antonescu, C. R.
    Genes Chromosomes and Cancer (2017)

    Fulltext@MSK | Save
  • A phase I/randomized phase II study of MLN0128 v.s pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304
    Meeting Abstract

    Tap, W. D.; Mahoney, M. R.; Jaslowski, A. J.; Horvath, L. E.; Schwartz, G.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy of sorafenib in patients with desmoid-type fibromatosis
    Meeting Abstract

    Munhor, R. R.; Lefkowitz, R. A.; Kuk, D.; Dickson, M. A.; D'Angelo, S. P.; Keohan, M. L.; Chi, P.; Crago, A. M.; Maki, R. G.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcomes of systemic therapy for patients with metastatic undifferentiated pleomorphic sarcoma (UPS)
    Meeting Abstract

    Adrianzen Herrera, D. A.; Kuk, D.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Agaram, N. P.; Antonescu, C. R.; Hameed, M.; Tap, W. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Platelet-derived growth factor receptor alpha promotes cancer stem-like cell phenotypes in sarcomas including metastasis and chemotherapy resistance
    Meeting Abstract

    Chang, K. K.; Yoon, C.; Tap, W. D.; Yoon, S. S.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence
    Meeting Abstract

    Cavnar, M. J.; Balachandran, V. P.; Chi, P.; Keohan, M. L.; Tap, W. D.; DeMatteo, R. P.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • A randomized phase 1b/2 study evaluating the safety and efficacy of doxorubicin (dox) with or without olaratumab (IMC-3G3), a human anti-platelet-derived growth factor α (pdgfrα) monoclonal antibody, in advanced soft tissue sarcoma (sts)
    Meeting Abstract

    Tap, W.; Jones, R. L.; Chmielowski, B.; Elias, A. D.; Adkins, D.; Van Tine, B. A.; Agulnik, M.; Cooney, M.; Livingston, M. B.; Pennock, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021
    Meeting Abstract

    Tap, W.; Papai, Z.; van Tine, B.; Attia, S.; Ganjoo, K.; Jones, R. L.; Schuetze, S.; Reed, D.; Chawla, S. P.; Riedel, R.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Exposure-response of olaratumab for survival outcomes and safety when combined with doxorubicin in soft tissue sarcoma (STS) patients
    Meeting Abstract

    Jones, R.; Mo, G.; Baldwin, J. R.; Nichols, R. D.; Ilaria, R. L.; Conti, I.; Cronier, D. M.; Tap, W. D.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: A phase 2 clinical trial
    Journal Article

    Dickson, M. A.; Schwartz, G. K.; Louise Keohan, M.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save